Menu
GeneBe

TNKS2

tankyrase 2, the group of Sterile alpha motif domain containing|Poly(ADP-ribose) polymerases|Ankyrin repeat domain containing

Basic information

Region (hg38): 10:91798425-91865475

Links

ENSG00000107854NCBI:80351OMIM:607128HGNC:15677Uniprot:Q9H2K2AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the TNKS2 gene.

  • Inborn genetic diseases (28 variants)
  • not provided (4 variants)
  • not specified (1 variants)
  • CIC-DUX Sarcoma (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the TNKS2 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
missense
28
clinvar
1
clinvar
29
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
3
clinvar
3
Total 0 0 28 0 5

Variants in TNKS2

This is a list of pathogenic ClinVar variants found in the TNKS2 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
10-91798715-G-A not specified Uncertain significance (Feb 06, 2023)2471693
10-91798761-C-T not specified Uncertain significance (Sep 29, 2023)3180491
10-91798764-C-T not specified Uncertain significance (Apr 21, 2022)2360981
10-91798767-G-C Uncertain significance (Nov 08, 2023)3236571
10-91813016-T-A not specified Uncertain significance (Dec 17, 2023)3180484
10-91813054-G-A not specified Uncertain significance (Sep 09, 2021)2229854
10-91813060-A-G not specified Uncertain significance (Nov 27, 2023)3180489
10-91813137-T-A not specified Uncertain significance (Jul 27, 2021)2353601
10-91813162-C-T not specified Uncertain significance (Jun 29, 2023)2608534
10-91813227-C-T Benign (Jan 06, 2022)1333083
10-91819285-A-G not specified Uncertain significance (Jun 03, 2022)2294056
10-91819544-G-T not specified Uncertain significance (Sep 20, 2023)3180490
10-91827038-A-G not specified Uncertain significance (Jun 21, 2022)2295916
10-91827200-G-A not specified Uncertain significance (Mar 03, 2023)2466448
10-91828378-A-G not specified Uncertain significance (Oct 25, 2022)2220711
10-91834033-T-G Benign (Apr 04, 2018)780884
10-91836961-T-G not specified Uncertain significance (Oct 03, 2022)2315039
10-91836963-G-A not specified Uncertain significance (Feb 12, 2024)3180479
10-91840597-A-C not specified Uncertain significance (Apr 25, 2023)2522066
10-91840654-G-A not specified Uncertain significance (Dec 16, 2023)3180480
10-91840657-G-A not specified Uncertain significance (May 04, 2022)2369748
10-91840660-G-C not specified Uncertain significance (Oct 05, 2023)3180481
10-91840723-G-A Benign (Jan 21, 2022)1335822
10-91842188-C-CA CIC-DUX Sarcoma not provided (-)805965
10-91842212-C-T not specified Conflicting classifications of pathogenicity (Dec 19, 2023)2672281

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
TNKS2protein_codingprotein_codingENST00000371627 2766965
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.00003671.001257090391257480.000155
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense3.123685800.6350.00002817581
Missense in Polyphen1703130.543133988
Synonymous-0.03632142131.000.00001082290
Loss of Function4.751958.00.3270.00000310767

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002760.000273
Ashkenazi Jewish0.00009930.0000992
East Asian0.000.00
Finnish0.0002780.000277
European (Non-Finnish)0.0001880.000185
Middle Eastern0.000.00
South Asian0.0001340.000131
Other0.0001630.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Poly-ADP-ribosyltransferase involved in various processes such as Wnt signaling pathway, telomere length and vesicle trafficking. Acts as an activator of the Wnt signaling pathway by mediating poly-ADP-ribosylation of AXIN1 and AXIN2, 2 key components of the beta-catenin destruction complex: poly-ADP- ribosylated target proteins are recognized by RNF146, which mediates their ubiquitination and subsequent degradation. Also mediates poly-ADP-ribosylation of BLZF1 and CASC3, followed by recruitment of RNF146 and subsequent ubiquitination. Mediates poly-ADP-ribosylation of TERF1, thereby contributing to the regulation of telomere length. May also regulate vesicle trafficking and modulate the subcellular distribution of SLC2A4/GLUT4-vesicles. Stimulates 26S proteasome activity. {ECO:0000269|PubMed:11739745, ECO:0000269|PubMed:11802774, ECO:0000269|PubMed:19759537, ECO:0000269|PubMed:21478859, ECO:0000269|PubMed:23622245}.;
Pathway
NAD+ biosynthetic pathways;Disease;Signaling by WNT;Signal Transduction;Regulation of PTEN stability and activity;Post-translational protein modification;Metabolism of proteins;Ub-specific processing proteases;PTEN Regulation;PIP3 activates AKT signaling;Deubiquitination;Signaling by WNT in cancer;Intracellular signaling by second messengers;Diseases of signal transduction;TCF dependent signaling in response to WNT;Degradation of AXIN;XAV939 inhibits tankyrase, stabilizing AXIN (Consensus)

Recessive Scores

pRec
0.125

Intolerance Scores

loftool
0.519
rvis_EVS
-1.29
rvis_percentile_EVS
5.08

Haploinsufficiency Scores

pHI
0.633
hipred
Y
hipred_score
0.648
ghis
0.653

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.677

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Tnks2
Phenotype
mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); embryo phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype;

Gene ontology

Biological process
protein polyubiquitination;protein ADP-ribosylation;Wnt signaling pathway;positive regulation of telomere maintenance via telomerase;multicellular organism growth;regulation of multicellular organism growth;protein localization to chromosome, telomeric region;protein auto-ADP-ribosylation;positive regulation of canonical Wnt signaling pathway;positive regulation of telomere capping;negative regulation of telomere maintenance via telomere lengthening
Cellular component
Golgi membrane;pericentriolar material;nuclear chromosome, telomeric region;nucleus;nuclear envelope;cytoplasm;cytosol;perinuclear region of cytoplasm
Molecular function
NAD+ ADP-ribosyltransferase activity;protein binding;enzyme binding;metal ion binding